Volume 28, Number 12—December 2022
Research
National Monkeypox Surveillance, Central African Republic, 2001–2021
Table
Characteristics | Confirmed cases, n = 99 | Suspected cases, n = 61 | No. contacts, n = 167 | p value |
---|---|---|---|---|
Sex | 0.6 | |||
F | 51 (53.1) | 37 (60.7) | 90 (53.9) | |
M | 45 (46.9) | 24 (39.3) | 77 (46.1) | |
Data missing |
3 |
0 |
0 |
|
Median age, y (IQR) |
15.5 (5.5–27) |
8 (2–23) |
27 (14–40) |
<0.001 |
Age group, y | <0.001 | |||
0–9 | 33 (35.9) | 30 (50.9) | 23 (17) | |
10–19 | 17 (18.5) | 9 (15.2) | 18 (13.3) | |
20–29 | 22 (23.9) | 11 (18.6) | 30 (22.2) | |
>30 | 20 (21.7) | 9 (15.3) | 64 (47.4) | |
Missing data |
7 |
2 |
32 |
|
Born before 1980† | 0.001 | |||
Y | 3 (3.3) | 4 (6.8) | 28 (20.7) | |
N | 89 (96.7) | 55 (93.2) | 107 (79.3) | |
Missing data |
7 |
2 |
32 |
|
Status/occupation | 0.001 | |||
Child | 37 (51.9) | 26 (61.9) | 5 (13.2) | |
Farmer | 16 (22.2) | 11 (28.2) | 15 (39.5) | |
Hunter/fisherman | 6 (8.3) | 0 | 1 (2.6) | |
Healthcare worker | 0 | 1 (2.4) | 4 (10.5) | |
Mine worker | 2 (2.8) | 0 | 6 (15.8) | |
Market trader | 2 (2.8) | 2 (4.8) | 0 | |
Other | 9 (12.5) | 2 (4.7) | 7 (18.4) | |
Missing data |
27 |
19 |
129 |
|
Reported contact with a human case | 0.004 | |||
Y | 44 (65.7) | 28 (75.7) | 36 (94.7) | |
N | 23 (34.3) | 9 (24.3) | 2 (5.3) | |
Missing data |
32 |
24 |
129 |
|
Contact setting | <0.001 | |||
Home | 40 (95.2) | 22 (81.5) | 17 (56.7) | |
Elsewhere | 2 (4.8) | 5 (18.5) | 13 (43.3) | |
Missing data |
57 |
34 |
137 |
|
Fever before rash | 0.1 | |||
Y | 51 (85) | 29 (96.7) | NA | |
N | 9 (15) | 1 (3.3) | NA | |
Missing data |
39 |
31 |
NA |
|
Diagnostic sample collected | <0.001 | |||
Blood | 45 (49.5) | 53 (86.9) | 46 (97.9) | |
Pus | 32 (35.2) | 5 (8.2) | 0 | |
Crust | 14 (15.4) | 3 (4.9) | 1 (2.1) | |
Missing data | 8 | 0 | 120 |
*Values indicate no. (%) of available data except as indicated. Number of cases missing data are indicated for each characteristic. NA, not applicable †Presumably persons born before 1980 were vaccinated against smallpox.
1These senior authors contributed equally to this article.
Page created: October 10, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.